Transient evoked oto-acoustic emission screening in newborns in Bogotá, Colombia : A retrospective study

Rojas Martínez, Jorge Armando; Bernal Villegas, Jaime Eduardo; García Acero, Mary Alexandra; Zarante Montoya, Ignacio Manuel; Ramírez Mora, Natalia; Bernal Villegas, Constanza; Gelvez Moyano, Nancy Yaneth; Tamayo Fernández, Martha Lucia

Mostrar el registro sencillo del registro

dc.rights.licence	Atribución-NoComercial 4.0 Internacional	*
dc.contributor.author	Rojas Martínez, Jorge Armando
dc.contributor.author	Bernal Villegas, Jaime Eduardo
dc.contributor.author	García Acero, Mary Alexandra
dc.contributor.author	Zarante Montoya, Ignacio Manuel
dc.contributor.author	Ramírez Mora, Natalia
dc.contributor.author	Bernal Villegas, Constanza
dc.contributor.author	Gelvez Moyano, Nancy Yaneth
dc.contributor.author	Tamayo Fernández, Martha Lucia
dc.date.accessioned	2019-12-09T21:55:59Z
dc.date.accessioned	2020-04-15T13:37:00Z
dc.date.available	2019-12-09T21:55:59Z
dc.date.available	2020-04-15T13:37:00Z
dc.date.created	2014-08-12
dc.identifier	https://www-clinicalkey-es.ezproxy.javeriana.edu.co/#!/content/journal/1-s2.0-S0165587614004480	spa
dc.identifier.issn	0165-5876 / 1872-8464 (Electrónico)	spa
dc.identifier.uri	http://hdl.handle.net/10554/46164
dc.format	PDF	spa
dc.format.mimetype	application/pdf	spa
dc.language	spa	spa
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/	*
dc.source	International Journal of Pediatric Otorhinolaryngology; Vol. 78 Núm. 10 (2014)	spa
dc.title	Transient evoked oto-acoustic emission screening in newborns in Bogotá, Colombia : A retrospective study	spa
dc.type	info:eu-repo/semantics/article
dc.type.hasversion	http://purl.org/coar/version/c_ab4af688f83e57aa
dc.description.quartilewos	Q4	spa
dc.description.quartilescopus	Q2	spa
dc.identifier.doi	https://doi.org/10.1016/j.ijporl.2014.08.004	spa
dc.description.paginas	1752-1755	spa
dc.format.soporte	Papel / Electrónico	spa
dc.subject.keyword	Transient evoked oto-acoustic emission	spa
dc.subject.keyword	Hearing loss	spa
dc.subject.keyword	Deafness	spa
dc.subject.keyword	Screening	spa
dc.subject.keyword	Newborn	spa
dc.description.abstractenglish	Objective: The aim of this study was to investígate the characteristics and performance of transient evoked oto-acoustic emission (TEOAE) hearing screening in newborns in Colombia, and analyze all possiblc variables and factors affccting thc rcsults. Materials and methods: An obscrvational, dcscriptivc and rctrospcctivc study with bivariatc analysis was pcrformcd. The study population consistcd of 56,822 newborns evaluated at thc prívate institution, PREGEN. TEOAE testing was carried out as a pedialric hearing screening test from December 2003 to March 2012. The database from PREGEN was revised, and the protocol for evalualion included the same screening test performed twice. Demographic characteristics were recorded and the newborn’s background was evaluated. Basic statistics of the qualitative and quantitative variables, and statistical analysis were obtained using the chi-square test. Residís: Of the 56,822 records examined, 0.28% were classed as abnormal, which corresponded to a prevalence of 1 in 350. In the screened newborns, 0.08% had a major abnormality or other clinical condition diagnosed, and 0.29% reported a family history of hearing loss. A prevalence of 6.7 in 10,000 was obtained for microtia, which is similar to the 6.4 in 10,000 previously reported in Colombia (database of the Latin-American Collaborative Study of Congenital Malformations - ECLAMC). Statistical analysis demonstrated an association bctwccn presenting with a major anomaly and a higher frequeney of abnormal rcsults on both TEOAE tests. Conclusions: Newborns in Colombia do not currcntly undergo screening for thc carly detection of hearing impairment. The results from this study suggest TEOAE screening tests, when performed twice, are able to detect hearing abnormalities in newborns. This highlights the need to improve the long-term evaluation and moniloring of patients in Colombia through diagnostic tests, and lo provide tests that are both sensitive and specific. Furthermore, the use of TEOAE screening is justified by the favorable cost: benefit ratio demonstrated in many countries worldwide.	spa
dc.type.local	Artículo de revista	spa
dc.contributor.corporatename	Pontificia Universidad Javeriana. Facultad de Medicina. Instituto de Genética Humana